Ross James Macrae

Title: Innovations of Ross James Macrae

Introduction

Ross James Macrae is a notable inventor based in Sandwich, GB. He has made significant contributions to the field of pharmaceuticals, holding a total of 4 patents. His work primarily focuses on controlled-release formulations that have important applications in medical treatments.

Latest Patents

One of his latest patents involves a controlled-release pharmaceutical formulation for oral administration. This formulation comprises 4-amino-6,7-dimethoxy-2-(5-methanesulfonamido-1,2,3,4-tetrahydroisoquinol-2-yl)-5-(2-pyridyl)quinazoline, or a pharmaceutically acceptable salt thereof, along with a suitable adjuvant, diluent, or carrier. The formulation is designed to release at least 50% by weight of the active ingredient after 6 hours under specific testing conditions. This innovation is particularly suitable for the treatment of Benign Prostatic Hyperplasia (BPH). Another significant patent focuses on controlled-release formulations containing a cGMP PDE-5 inhibitor, which are useful in the treatment or prevention of sexual dysfunction.

Career Highlights

Ross James Macrae is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to contribute to advancements in pharmaceutical formulations that enhance patient care and treatment efficacy.

Collaborations

Throughout his career, Macrae has collaborated with notable colleagues, including Valerie Denise Harding and Ronald James Ogilvie. These collaborations have further enriched his research and development efforts in the pharmaceutical field.

Conclusion

Ross James Macrae's innovative contributions to pharmaceutical formulations demonstrate his commitment to improving medical treatments. His patents reflect a deep understanding of drug delivery systems and their applications in healthcare.